Rights and permissions
About this article
Cite this article
Who benefits from pharma's huge R&D outlay?. Pharmacoecon. Outcomes News 448, 2 (2004). https://doi.org/10.2165/00151234-200404480-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404480-00002